
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $2.6B | -- | -- | $1.73 | -- |
08/11/2025 | Q2 | $2.5B | -- | -- | $1.40 | -- |
05/05/2025 | Q1 | $2.3B | $2.4B | -$0.19 | $0.39 | -$0.58 |
02/18/2025 | Q4 | $2.4B | $2.4B | -$17.50 | $1.20 | -$18.70 |
11/05/2024 | Q3 | $2.7B | $2.6B | $1.06 | $2.84 | -$1.78 |
08/01/2024 | Q2 | $2.7B | $2.7B | $1.41 | $2.74 | -$1.33 |
05/08/2024 | Q1 | $2.7B | $2.6B | $1.10 | $1.91 | -$0.81 |
02/20/2024 | Q4 | $2.6B | $2.6B | $6.37 | $2.31 | $4.06 |
11/06/2023 | Q3 | $2.8B | $2.7B | $8.69 | $2.23 | $6.46 |
08/07/2023 | Q2 | $3B | $2.8B | $2.01 | $2.48 | -$0.47 |
05/10/2023 | Q1 | -- | $2.9B | $0.83 | -- | -- |
02/24/2023 | Q4 | -- | $2.3B | $7.02 | -- | -- |
11/04/2022 | Q3 | -- | $2.3B | $1.75 | -- | -- |
07/28/2022 | Q2 | -- | $2.5B | $3.98 | -- | -- |
04/29/2022 | Q1 | -- | $2.5B | $4.61 | -- | -- |
01/27/2022 | Q4 | -- | $2.3B | $4.79 | -- | -- |
10/21/2021 | Q3 | -- | $2.3B | $4.56 | -- | -- |
07/22/2021 | Q2 | -- | $2.2B | $4.77 | -- | -- |
04/22/2021 | Q1 | -- | $1.8B | $2.82 | -- | -- |
01/28/2021 | Q4 | -- | $1.6B | $12.50 | -- | -- |
10/25/2020 | Q3 | -- | $1.4B | $1.75 | -- | -- |
07/28/2020 | Q2 | -- | $1.2B | $0.90 | -- | -- |
04/28/2020 | Q1 | -- | $1.5B | $1.82 | -- | -- |
01/30/2020 | Q4 | -- | $1.4B | $0.36 | -- | -- |
10/21/2019 | Q3 | -- | $1.6B | $2.13 | -- | -- |
07/22/2019 | Q2 | -- | $1.6B | $1.66 | -- | -- |
04/22/2019 | Q1 | -- | $1.7B | $2.63 | -- | -- |
01/28/2019 | Q4 | -- | $1.7B | $0.75 | -- | -- |
10/19/2018 | Q3 | -- | $1.8B | $2.96 | -- | -- |
07/20/2018 | Q2 | -- | $1.8B | $2.52 | -- | -- |
04/17/2018 | Q1 | -- | $1.9B | $2.66 | -- | -- |
01/26/2018 | Q4 | -- | $1.6B | $1.49 | -- | -- |
10/17/2017 | Q3 | -- | $1.6B | $1.65 | -- | -- |
07/25/2017 | Q2 | -- | $1.5B | $1.66 | -- | -- |
04/18/2017 | Q1 | -- | $1.5B | $1.30 | -- | -- |
02/01/2017 | Q4 | -- | $1.3B | $1.13 | -- | -- |
10/18/2016 | Q3 | -- | $1.3B | $1.81 | -- | -- |
07/26/2016 | Q2 | -- | $1.4B | $1.50 | -- | -- |
04/19/2016 | Q1 | -- | $1.4B | $1.73 | -- | -- |
01/22/2016 | Q4 | -- | $1.3B | -$1.94 | -- | -- |
10/20/2015 | Q3 | -- | $1.4B | $1.07 | -- | -- |
Celanese reported $2.4B worth of top line sales in its most recent quarter.
Celanese announced earnings per share of -$0.19 which represents a miss of analyst forecast a $0.39 per share.
Celanese reported $476M that represents $4.35 per share over the last quarter.
Celanese's earnings are forecast to decrease from -$13.93 per share to $8.10 per share next year representing a decrease of -54.8%.
Celanese's next earnings date is August 11, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.